December 21, 2020
With FDA approval of the Moderna COVID-19 vaccine on December 18, the College has updated its guidance on the two mRNA vaccine products, including information about allergic reactions.
Second dose of COVID-19 vaccine not recommended for patients with severe reaction [update]
December 21, 2020
